April 29 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday published the final rule to ensure safety and effectiveness of laboratory developed tests (LDTs), which are designed, manufactured and used within a clinical laboratory. (Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini Ganguli)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
197.1 USD | -2.04% | -7.53% | -13.29% |
May. 23 | Some of the biggest splits in Corporate America | RE |
May. 16 | Declaration of Voting Results by Laboratory Corporation of America Holdings | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
197.1 USD | -2.04% | -7.53% | 16.61B | ||
140 USD | -1.28% | -1.68% | 15.56B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.29% | 16.61B | |
+16.49% | 82.59B | |
-29.52% | 69.86B | |
0.00% | 26.5B | |
+3.31% | 17.29B | |
+1.57% | 15.56B | |
+71.63% | 13.2B | |
+1.53% | 12.75B | |
+70.68% | 12.6B | |
+6.03% | 12.19B |
- Stock Market
- Equities
- LH Stock
- News Labcorp Holdings Inc.
- US FDA publishes final rule for laboratory developed tests